Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3501671012 | Dyphylline 200 mg and guaifenesin 200 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
3501672017 | Diprophylline 200 mg and guaifenesin 200 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
3678323019 | Product containing precisely diprophylline 200 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
105046801000001111 | Dyphylline+guaifenesin 200mg/200mg tablet | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom Edition module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely diprophylline 200 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Is a | Medicinal product acting as expectorant agent (product) | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely diprophylline 200 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Is a | Smooth muscle relaxant | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely diprophylline 200 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Is a | Respiratory smooth muscle relaxant | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely diprophylline 200 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Is a | Product containing diprophylline in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely diprophylline 200 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Has active ingredient | Diprophylline | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely diprophylline 200 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Has active ingredient | Respiratory smooth muscle relaxant | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely diprophylline 200 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Has active ingredient | Smooth muscle relaxant | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely diprophylline 200 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Is a | Product containing diprophylline and guaifenesin | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely diprophylline 200 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Has active ingredient | Bronchodilator | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely diprophylline 200 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Has active ingredient | Guaifenesin | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely diprophylline 200 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Has active ingredient | Substance with phosphodiesterase inhibitor mechanism of action | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely diprophylline 200 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely diprophylline 200 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Has active ingredient | Xanthine | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely diprophylline 200 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Has active ingredient | Musculoskeletal system agent | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely diprophylline 200 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely diprophylline 200 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Is a | Product containing diprophylline in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely diprophylline 200 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Has basis of strength substance | Guaifenesin | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely diprophylline 200 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 200 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely diprophylline 200 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely diprophylline 200 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely diprophylline 200 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely diprophylline 200 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Has basis of strength substance | Diprophylline | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely diprophylline 200 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 200 | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely diprophylline 200 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely diprophylline 200 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely diprophylline 200 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely diprophylline 200 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Has active ingredient | Diprophylline | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely diprophylline 200 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Has basis of strength substance | Diprophylline | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely diprophylline 200 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Has active ingredient | Guaifenesin | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely diprophylline 200 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Has basis of strength substance | Guaifenesin | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely diprophylline 200 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Has precise active ingredient | Diprophylline | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely diprophylline 200 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Has precise active ingredient | Guaifenesin | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely diprophylline 200 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely diprophylline 200 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Is a | Product containing diprophylline and guaifenesin in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely diprophylline 200 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely diprophylline 200 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Is a | Product containing only diprophylline and guaifenesin in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely diprophylline 200 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Plays role | Expectorant therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely diprophylline 200 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Has precise active ingredient | Guaifenesin | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely diprophylline 200 milligram and guaifenesin 200 milligram/1 each conventional release oral tablet | Has precise active ingredient | Diprophylline | true | Inferred relationship | Existential restriction modifier | 1 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets